Cancer Letters, 1872-7980

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma

    Miyashita, N., Horie, M., Mikami, Y., Urushiyama, H., Fukuda, K., Miyakawa, K., Matsuzaki, H., Makita, K., Morishita, Y., Harada, H., Backman, M., Lindskog, C., Hans Brunnström, Micke, P., Nagase, T. & Saito, A., 2020, I : Cancer Letters. 489, s. 121-132 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2019
  4. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

    Wu, Z., Fournel, L., Stadler, N., Liu, J., Boullier, A., Hoyeau, N., Fléjou, J. F., Duchatelle, V., Djebrani-Oussedik, N., Agopiantz, M., Ségal-Bendirdjian, E., Gompel, A., Alifano, M., Olle Melander, Trédaniel, J. & Forgez, P., 2019, I : Cancer Letters. 444, s. 147-161 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2018
  6. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer

    Bellamkonda, K., Shakti Ranjan Satapathy, Douglas, D., Chandrashekar, N., Selvanesan, B. C., Liu, M., Savari, S., Jonsson, G. & Anita Sjölander, 2018 nov 28, I : Cancer Letters. 437, s. 13-24 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2017
  8. Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia

    Sausan A. Moharram, Kinjal Shah, Khanum, F., Marhäll, A., Mohiuddin, G. & Julhash U. Kazi, 2017 okt 1, I : Cancer Letters. 405, s. 73-78 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

    Mohiuddin, G., Sausan A. Moharram, Marhäll, A. & Julhash U. Kazi, 2017 apr 28, I : Cancer Letters. 392, s. 9-16 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. MicroRNAs as cancer therapeutics: A step closer to clinical application

    Catela Ivkovic, T., Gjendine Voss, Cornella, H. & Yvonne Ceder, 2017, I : Cancer Letters. 407, s. 113-122

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  11. 2016
  12. Genetic variation in the major mitotic checkpoint genes associated with chromosomal aberrations in healthy humans

    Asta Försti, Frank, C., Smolkova, B., Kazimirova, A., Barancokova, M., Vymetalkova, V., Kroupa, M., Naccarati, A., Vodickova, L., Buchancova, J., Dusinska, M., Musak, L., Vodicka, P. & Kari Hemminki, 2016 okt 1, I : Cancer Letters. 380, 2, s. 442-446 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Risk of second primary cancers after malignant mesothelioma and vice versa

    Chen, T., Kharazmi, E., Lou, J., Zhang, X., Kristina Sundquist & Hemminki, K., 2016 aug 28, I : Cancer Letters. 379, 1, s. 94-99 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Braekeveldt, N., Wigerup, C., Tadeo, I., Beckman, S., Caroline Sandén, Jönsson, J., Jonas S Erjefält, Berbegall, A. P., Anna Börjesson, Backman, T., Ingrid Øra, Navarro, S., Noguera, R., David Gisselsson, Sven Påhlman & Daniel Bexell, 2016, I : Cancer Letters. 375, 2, s. 384-389

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2015
  16. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.

    Welinder, C., Bo Jansson, Lindell, G. & Wenner, J., 2015, I : Cancer Letters. 358, 1, s. 43-46

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.

    Chen, T., Fallah, M., Jansen, L., Castro, F. A., Krilavicuite, A., Katalinic, A., Eisemann, N., Emrich, K., Holleczek, B., Geiss, K., Eberle, A., Jan Sundquist, Brenner, H. & Kari Hemminki, 2015, I : Cancer Letters. 369, 1, s. 152-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.

    Mattsson, J. S. M., Bergman, B., Grinberg, M., Edlund, K., Marincevic, M., Karin Jirström, Pontén, F., Hengstler, J. G., Rahnenführer, J., Karlsson, M. G., Karlsson, C., Helenius, G., Botling, J., Micke, P. & Gulyas, M., 2015, I : Cancer Letters. 356, 2, s. 837-845

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study.

    Rucci, N., Capulli, M., Olstad, O. K., Patrik Önnerfjord, Tillgren, V., Gautvik, K. M., Heinegård, D. & Teti, A., 2015, I : Cancer Letters. 358, 1, s. 67-75

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2012
  21. Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.

    Siker Kimbung, Biskup, E., Johansson, I., Kristina Aaltonen, Ottosson-Wadlund, A., Sofia Gruvberger, Cunliffe, H., Fadeel, B., Niklas Loman, Berglund, P. & Ingrid Hedenfalk, 2012, I : Cancer Letters. 319, 2, s. 232-241

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2011
  23. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

    Balassiano, K., Lima, S., Jenab, M., Overvad, K., Tjonneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Canzian, F., Kaaks, R., Boeing, H., Meidtner, K., Trichopoulou, A., Laglou, P., Vineis, P., Panico, S., Palli, D., Grioni, S., Tumino, R., Lund, E., Bueno-de-Mesquita, H. B. & 22 andra, Numans, M. E., Peeters, P. H. M., Ramon Quiros, J., Sanchez, M-J., Navarro, C., Ardanaz, E., Dorronsoro, M., Hallmans, G., Stenling, R., Ehrnström, R., Sara Regnér, Allen, N. E., Travis, R. C., Khaw, K-T., Offerhaus, G. J. A., Sala, N., Riboli, E., Hainaut, P., Scoazec, J-Y., Sylla, B. S., Gonzalez, C. A. & Herceg, Z., 2011, I : Cancer Letters. 311, 1, s. 85-95

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2010
  25. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

    Stannard, K. A., Collins, P. M., Ito, K., Sullivan, E. M., Scott, S. A., Gabutero, E., Grice, I. D., Low, P., Nilsson, U., Hakon Leffler, Blanchard, H. & Ralph, S. J., 2010, I : Cancer Letters. 299, 2, s. 95-110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2009
  27. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells

    Lin, C., Chen, D., Gong, M., Na, M., Li, L., Wu, H., Jiang, L., Qian, Y., Fang, G. & Xue, X., 2009, I : Cancer Letters. 284, 2, s. 141-148

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate.

    Fang Cheng, Johnsson, R., Nilsson, J., Lars-Åke Fransson, Ulf Ellervik & Katrin Mani, 2009, I : Cancer Letters. 273, s. 148-154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia

    Micci, F., Panagopoulos, I., Haugom, L., Andersen, H. K., Tjonnfjord, G. E., Beiske, K. & Heim, S., 2009, I : Cancer Letters. 277, 2, s. 205-211

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2008
  31. B cell lymphomas express CX(3)CR1 a non-B cell lineage adhesion molecule.

    Ulrika Andreasson, Sara Ek, Merz, H., Rosenquist, R., Andersen, N., Mats Jerkeman, Michael Dictor & Borrebaeck, C. A. K., 2008, I : Cancer Letters. 259, 2, s. 138-145

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Identification of differentially expressed genes after PPM1D silencing in breast cancer.

    Pärssinen, J., Alarmo, E-L., Khan, S., Karhu, R., Mauno Vihinen & Kallioniemi, A., 2008, I : Cancer Letters. 259, 1, s. 61-70

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays

    Ellmark, P., Högerkorp, C-M., Sara Ek, Beelov, L., Berglund, M., Rosenquist, R., Christopherson, R. & Carl Borrebaeck, 2008, I : Cancer Letters. 265, s. 98-106

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. 2007
  35. Fusion genes in angiomatoid fibrous histiocytoma

    Karolin Hansén Nord, Micci, F., Meis-Kindblom, J. M., Kindblom, L-G., Bacchini, P., Nils Mandahl, Fredrik Mertens & Panagopoulos, I., 2007 jun 18, I : Cancer Letters. 251, 1, s. 158-163 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Low dose Zebularine treatment enhances immunogenicity of tumor cells

    Liu, H., Xue, Z., Sjögren, H. O., Leif Salford & Widegren, B., 2007, I : Cancer Letters. 257, 1, s. 107-115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation

    Zhang, H., Jin, Y., Chen, X., Jin, C., Law, S., Tsao, S-W. & Kwong, Y-L., 2007, I : Cancer Letters. 245, 1-2, s. 184-194

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2006
  39. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.

    Liu, F., Cheng, Y., Wu, J., Tauschel, H-D. & Rui-Dong Duan, 2006, I : Cancer Letters. 235, 1, s. 141-146

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2004
  41. Mitotic instability associated with late genomic changes in bone and soft tissue tumours.

    David Gisselsson Nord, Pålsson, E., Yu, C., Fredrik Mertens & Nils Mandahl, 2004, I : Cancer Letters. 206, 1, s. 69-76

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics

    Fransson, J., Sara Ek, Ellmark, P., Söderlind, E., Carl Borrebaeck & Furebring, C., 2004, I : Cancer Letters. 208, 2, s. 235-242

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1.

    Håkan Axelson, 2004, I : Cancer Letters. 204, 2, s. 171-178

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 2003
  45. Hypoxia-induced dedifferentiation in neuroblastoma cells.

    Annika Jögi, Ingrid Øra, Helén Nilsson, Poellinger, L., Håkan Axelson & Sven Påhlman, 2003, I : Cancer Letters. 197, 1-2, s. 145-150

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 1999
  47. Fluorescence diagnostics and kinetic studies in the head and neck region utilizing low-dose delta-aminolevulinic acid sensitization

    Wang, I., Clemente, L. P., Pratas, R. M. G., Cardoso, E., Clemente, M. P., Montan, S., Sune Svanberg & Katarina Svanberg, 1999, I : Cancer Letters. 135, 1, s. 11-19

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. 1998
  49. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences

    D Gisselsson, M Höglund, O'Brien, K. P., Dumanski, J. P., F Mertens & N Mandahl, 1998 nov 27, I : Cancer Letters. 133, 2, s. 129-34 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. 1997
  51. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues

    Heyerdahl, H., Wang, I., Liu, D. L., Berg, R., Andersson-Engels, S., Peng, Q., Moan, J., Sune Svanberg & Katarina Svanberg, 1997, I : Cancer Letters. 112, 2, s. 225-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy

    Liu, D. L., Andersson-Engels, S., Sturesson, C., Katarina Svanberg, Hakansson, C. H. & Sune Svanberg, 1997, I : Cancer Letters. 111, 1-2, s. 157-165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. 1996
  54. Repeated immunotherapy using intratumoural injection with recombinant interleukin-2 and tumour-infiltrating lymphocytes inhibits growth of breast cancer and induces apoptosis of tumour cells

    Liu, D. L., Yang, M. Q., Eberhardt, J. & B. Persson, 1996 jun 5, I : Cancer Letters. 103, 2, s. 131-136 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. 1994
  56. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

    Åke Borg, Bo Baldetorp, Mårten Fernö, Dick Killander, Håkan Olsson, Ryden, S. & Sigurdsson, H., 1994, I : Cancer Letters. 81, 2, s. 137-144

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3)

    Satish Batra & Fadeel, I., 1994, I : Cancer Letters. 77, 1, s. 57-63

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. 1992
  59. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction

    Nannmark, U., Sennerby, L., Lars Magnus Bjursten, Skolnik, G. & Bagge, U., 1992, I : Cancer Letters. 62, 1, s. 83-86

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift